Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sanofi SA (NASDAQ:GCVRZ)

0.43
Delayed Data
As of Mar 22
 +0.0045 / +1.06%
Today’s Change
0.09
Today|||52-Week Range
0.50
+13.16%
Year-to-Date
Will Sanofi (SNY) Prove to be a Suitable Value Stock?
Mar 22 / Zacks.com - Paid Partner Content
Towerview Llc Buys Syngenta AG, Time Warner, EVINE Live, Sells International Business...
Mar 16 / GuruFocus News - Paid Partner Content
Amgen (AMGN): Repatha Outcomes Data Disappoint, Shares Drop
Mar 20 / Zacks.com - Paid Partner Content
Amgen's Repatha Meets Primary Endpoint in Phase III Study
Mar 14 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: U.S. Bancorp, Verizon, EOG Resources, Sanofi and N...
Mar 17 / Zacks.com - Paid Partner Content
3 Companies That Probably Won't Survive Till 2019
Mar 13 / MotleyFool.com - Paid Partner Content
What are Sanofi's (SNY) Strengths and Challenges in 2017?
Mar 17 / Zacks.com - Paid Partner Content
Novo Nordisk's Diabetes Unit Strong; Generic Pressure Stays
Mar 13 / Zacks.com - Paid Partner Content
Keryx Focuses on Kidney Drug Aurexia Despite Generic Threat
Mar 16 / Zacks.com - Paid Partner Content
3 Growth Stocks I'd Buy Right Now
Mar 11 / MotleyFool.com - Paid Partner Content
New Stock Research Reports for Verizon, EOG, and U.S. Bancorp
Mar 16 / Zacks.com - Paid Partner Content
Why Amgen (AMGN) Stock Rallied After Q4 Earnings Release?
Mar 10 / Zacks.com - Paid Partner Content